Showing results (231-240 of 372) with videos related to

Sort By:
Pageof 38
Journal of Neuropathology and Experimental Neurology|June 6, 2007
Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcomeJohan M Kros, Thierry Gorlia, Mathilde C Kouwenhoven, et al.
Cancer Research|July 18, 2008
Temozolomide preferentially depletes cancer stem cells in glioblastomaDagmar Beier, Stefanie Röhrl, Deepu R Pillai, et al.
The Lancet. Oncology|August 1, 2014
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastomaMichael Weller, Martin van den Bent, Kirsten Hopkins, et al.
Cancer Cell|October 19, 2013
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastomaQi-Wen Fan, Christine K Cheng, W Clay Gustafson, et al.
Neuro-Oncology Advances|January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trialAnnika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
Frontiers in Immunology|March 3, 2020
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the BrainDayana Herrera-Rios, Sadaf S Mughal, Sarah Teuber-Hanselmann, et al.
International Journal of Cancer|May 14, 2019
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cellsMor Varon, Tal Levy, Gal Mazor, et al.
Aging|November 21, 2014
Proteome-wide analysis reveals an age-associated cellular phenotype of in situ aged human fibroblastsDaniel M Waldera-Lupa, Faiza Kalfalah, Ana-Maria Florea, et al.
Journal of Neurosurgery|March 3, 2005
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopyFrank Willi Floeth, Dirk Pauleit, Hans-Jörg Wittsack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent TumorsJörg Felsberg, Bettina Hentschel, Kerstin Kaulich, et al.
Pageof 38